CashuSITE Centers Prepares for Q4 Earnings with Enhanced Stakeholder Communication Strategies10 months ago
CashuSITE Centers Prioritizes Transparency Ahead of Q4 Earnings Release on February 27, 202510 months ago
CashuSITE Centers Announces 2024 Tax Allocations and Distribution Plans for Shareholders10 months ago
prnewswire.comWilliams Cancer Institute Presents Data on Combined Pulsed Electrical Field Ablation and Intratumoral Immunotherapy at SITC 202516 days ago
prnewswire.comAkeso Unveils Promising Preclinical Data for IL-1RAP Targeting Antibody (AK135) at SITC 202519 days ago
prnewswire.comLunit AI Maps the Tumor-Immune Landscape to Predict Immunotherapy Response and Discover New Antibody Targets at SITC 202519 days ago
prnewswire.comVerismo Therapeutics to Announce Upcoming Presentations at SITC and ASH Annual Meetings21 days ago
prnewswire.comCREATE Medicines to Present Late-Breaking Clinical Data on MT-302 at the Society for Immunotherapy of Cancer (SITC) 40th Annual Meeting23 days ago
benzinga.comRoku, SPS Commerce, Newell Brands And Other Big Stocks Moving Lower In Friday's Pre-Market Session26 days ago
prnewswire.comFirst Dual-Positive Immunotherapy with PFS and OS Benefit in EGFR+ NSCLC After EGFR-TKI Progression: Ivonescimab Final OS Analysis from HARMONi-A to Be Presented at SITC 202527 days ago
prnewswire.comPancreatic Cancer Clinical Trial Data for Diakonos Oncology's DOC1021 Cell-Based Immunotherapy to be Presented at the Society for Immunotherapy of Cancer (SITC) 40th Annual Meetingabout 1 month ago